Ad is loading...
MENU
SLDB Solid Biosciences Forecast, Technical & Fundamental Analysis
a developer of novel gene therapy platform for advancing disease
Industry Biotechnology
Show more...
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I. Advisor
published General Information
General Information
a developer of novel gene therapy platform for advancing disease
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
500 Rutherford Avenue
Phone
+1 617 337-4680
Employees
88
Web
https://www.solidbio.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| HQIIX | 22.46 | 0.24 | +1.08% |
| Hartford Equity Income I | |||
| PAXLX | 15.22 | 0.11 | +0.73% |
| Impax Large Cap Fund Individual Investor | |||
| RTIYX | 10.61 | 0.04 | +0.38% |
| Russell Inv Multifactor Intl Eq Y | |||
| FWRIX | 11.16 | 0.03 | +0.27% |
| Fidelity Advisor Global Real Estate I | |||
| HFEAX | 45.31 | -0.17 | -0.37% |
| Janus Henderson European Focus A | |||
SLDB and Stocks
Correlation & Price change
A.I.dvisor indicates that over the last year, SLDB has been loosely correlated with ACLX. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if SLDB jumps, then ACLX could also see price increases.
1D
1W
1M
1Q
6M
1Y
5Y
| Ticker / NAME | Correlation To SLDB | 1D Price Change % | ||
|---|---|---|---|---|
| SLDB | 100% | +5.44% | ||
| ACLX - SLDB | 42% Loosely correlated | N/A | ||
| ATHE - SLDB | 38% Loosely correlated | +1.90% | ||
| KROS - SLDB | 36% Loosely correlated | -0.55% | ||
| MOLN - SLDB | 35% Loosely correlated | +4.23% | ||
| ABOS - SLDB | 35% Loosely correlated | -2.53% | ||
More | ||||